The Quantellect read.As of Nov 19, 2026, 5 active firms cover Immatics NV: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $15.00 to $25.00, a moderate spread. The average target of $20.25 sits 232% above the current $6.11. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.57 next quarter toward $-1.98 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$20.25
+231.7% upside
Average target across 4 active firms as of Nov 19, 2026 vs $6.11 current
Highest Target$25.00
Average Target$20.25
Lowest Target$15.00
Detailed analyst forecasts for IMTX
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate IMTX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IMTX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.57
Range $-0.61 – $-0.52 · 2 analysts · +12% YoY
Next period, 2 analysts expect Immatics NV to earn $-0.57 a share (range $-0.61 – $-0.52), versus $-0.51 a year earlier. Full-year consensus is $-2.13, growing to $-1.98 the year after.
REVENUE · NEXT QUARTER
$5.5M
Range $0 – $8.9M · 2 analysts · -38% YoY
Revenue is expected to reach $5.5M (range $0 – $8.9M), -38.2% year-over-year. Full-year consensus is $35.2M, rising to $31.4M next year.
Top analysts covering Immatics NV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMTX.
#1
Geulah Livshits
Chardan Capital · Rank #104
Buy
$25.00+309.5% to target
Overall win rate
43%
+ Follow
#2
Graig Suvannavejh
Mizuho · Rank #239
Buy
$25.00+309.5% to target
Overall win rate
40%
+ Follow
#3
PJ
Paul Jeng
Guggenheim
Buy
$19.00+211.2% to target
Coverage
—
+ Follow
#4
NL
Nicholas Lorusso
TD Cowen
Buy
No targeton IMTX
Coverage
—
+ Follow
#5
RS
Rajan Sharma
Goldman Sachs
Buy
$11.80+93.3% to target
Coverage
—
+ Follow
IMTX stock forecast FAQ
What is IMTX's average 12-month price target?+
The 4 active firms with a live target average $20.25 for Immatics NV over the next 12 months, ranging from a $25.00 high to a $15.00 low, as of Nov 19, 2026.
Is IMTX stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IMTX?+
The Street-high target is $25.00 (Chardan Capital), and the Street-low is $15.00 (Stifel). The average of all 4 active-firm targets is $20.25.
How many active Wall Street firms cover IMTX?+
5 active firms have a recognized rating on Immatics NV as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IMTX?+
Among analysts who currently cover IMTX, Geulah Livshits of Chardan Capital has the strongest overall Quantellect track record (Rank #104). Their current call is Buy with a $25.00 target.
What is Immatics NV's projected EPS for next quarter?+
The consensus estimate is $-0.57 per share (range $-0.61 – $-0.52) across 2 analysts. Full-year EPS is projected at $-2.13, rising to $-1.98 the following year.
How much revenue is Immatics NV expected to report next quarter?+
Consensus revenue is $5.5M (range $0 – $8.9M). Full-year revenue is projected at $35.2M, growing to $31.4M next year.
Have analysts been upgrading or downgrading IMTX lately?+
As of Nov 19, 2026, 5 of 5 active firms rate IMTX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.